National Research Share Price Today
(NASDAQ: NRC)

Name: National Research Share Price Today (NASDAQ: NRC) - National Research Stock Price Live Quote | INDmoney
Brand: INDmoney
Rating: 4.7 (371551 reviews)

National Research share price is $14.26 & ₹1,240.18 as on 6 Mar 2025, 2.30 'hrs' IST

$14.26

▲

0.16

(1.13%)

Market is closed - opens 8 PM, 06 Mar 2025

View live National Research share price in Dollar and Rupees. Guide to invest in National Research stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in National Research, along with analyst recommendations, forecasts, and comprehensive financials.

National Research share price movements

Today's Low: $13.99
Today's High: $14.45
$14.26
1.89%
Downside
Day's Volatility :3.15%
Upside
1.28%
52 Weeks Low: $13.92
52 Weeks High: $40.77
$14.26
2.38%
Downside
52 Weeks Volatility :65.86%
Upside
65.02%

National Research (NRC) Returns

Period	National Research Corp	Sector (Health Care)	Index (Russel 2000)
3 Months	-26.68%	2.1%	0.0%
6 Months	-34.87%	-4.1%	0.0%
1 Year	-65.04%	2.2%	0.0%
3 Years	-61.19%	11.8%	-11.6%

National Research (NRC) Key Statistics

in dollars & INR

Previous Close	$14.1
Open	$14.2
Today's High	$14.4456
Today's Low	$13.99
Market Capitalization	$325.5M
Today's Volume	$33.9K
52 Week High	$40.77
52 Week Low	$13.92
Revenue TTM	$143.1M
EBITDA	$41.2M
Earnings Per Share (EPS)	$1.04
PE Ratio	13.56
Dividend Yield	3.39%
Profit Margin	17.32%
Quarterly Earnings Growth YOY	-0.22%
Return On Equity TTM	61.77%

How to invest in National Research Stock (NRC) from India?

It is very easy for Indian residents to invest directly in National Research from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the National Research stock in both Indian Rupees (INR) and US Dollars (USD). Search for National Research or NRC on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of National Research or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of National Research shares which would translate to 0.061 fractional shares of National Research as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like National Research, in just a few clicks!

Returns in National Research (NRC) for Indian investors in Rupees

The National Research stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

National Research investment value today

Current value as on today

₹40,321

Returns

₹59,679

(-59.68%)

Returns from National Research Stock

₹64,642 (-64.64%)

Dollar Returns

₹4,963 (+4.96%)

Indian investors sentiment towards National Research (NRC)

-20%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Search interest for National Research Stock from India on INDmoney has decreased by -20% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in National Research

Kayne Anderson Rudnick Investment Management LLC
13.14%
BlackRock Inc
5.23%
Vanguard Group Inc
4.13%
Morgan Stanley - Brokerage Accounts
3.97%
Dimensional Fund Advisors, Inc.
2.52%
Geode Capital Management, LLC
1.89%

Analyst Recommendation on National Research

Sell

0%Buy

37%Hold

62%Sell

Based on 8 Wall street analysts offering stock ratings for National Research(by analysts ranked 0 to 5 stars)

Based on 8 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Insights on National Research Stock (Ticker Symbol: NRC)

Price Movement
In the last 3 months, NRC stock has moved down by -26.7%
Increasing Revenue
Revenue is up for the last 2 quarters, 35.02M → 35.81M (in $), with an average increase of 2.2% per quarter
Decreasing Net Profit
Netprofit is down for the last 4 quarters, 8.85M → 5.68M (in $), with an average decrease of 13.0% per quarter
NRC vs DOCS (1 yr)
In the last 1 year, Doximity, Inc. has given 144.5% return, outperforming this stock by 208.9%
NRC vs HQY (3 yr)
In the last 3 years, Healthequity Inc has given 39.9% return, outperforming this stock by 101.9%
Price to Sales
ForNRC every $1 of sales, investors are willing to pay $2.3, whereas for Doximity, Inc., the investors are paying $23.0 for every $1 of sales.

NRC National Research Financials in INR & Dollars

	FY18	Y/Y Change
Revenue	$119.7M	↑ 1.81%
Net Income	$30.0M	↑ 30.96%
Net Profit Margin	25.1%	↑ 5.58%

	FY19	Y/Y Change
Revenue	$128.0M	↑ 6.93%
Net Income	$32.4M	↑ 7.85%
Net Profit Margin	25.32%	↑ 0.22%

	FY20	Y/Y Change
Revenue	$133.3M	↑ 4.14%
Net Income	$37.3M	↑ 14.98%
Net Profit Margin	27.96%	↑ 2.64%

	FY21	Y/Y Change
Revenue	$148.0M	↑ 11.01%
Net Income	$37.5M	↑ 0.55%
Net Profit Margin	25.32%	↓ 2.64%

	FY22	Y/Y Change
Revenue	$151.6M	↑ 2.44%
Net Income	$31.8M	↓ 15.12%
Net Profit Margin	20.98%	↓ 4.34%

	FY23	Y/Y Change
Revenue	$148.6M	↓ 1.97%
Net Income	$31.0M	↓ 2.61%
Net Profit Margin	20.84%	↓ 0.14%

	Q2 FY23	Q/Q Change
Revenue	$36.2M	↓ 0.86%
Net Income	$7.3M	↑ 4.44%
Net Profit Margin	20.11%	↑ 1.02%

	Q3 FY23	Q/Q Change
Revenue	$37.9M	↑ 4.93%
Net Income	$7.9M	↑ 8.29%
Net Profit Margin	20.76%	↑ 0.65%

	Q4 FY23	Q/Q Change
Revenue	$38.0M	↑ 0.15%
Net Income	$8.9M	↑ 12.47%
Net Profit Margin	23.31%	↑ 2.55%

	Q1 FY24	Q/Q Change
Revenue	$35.3M	↓ 7.07%
Net Income	$6.4M	↓ 28.21%
Net Profit Margin	18.01%	↓ 5.3%

	Q2 FY24	Q/Q Change
Revenue	$35.0M	↓ 0.83%
Net Income	$6.2M	↓ 2.89%
Net Profit Margin	17.63%	↓ 0.38%

	Q3 FY24	Q/Q Change
Revenue	$35.8M	↑ 2.28%
Net Income	$5.7M	↓ 7.89%
Net Profit Margin	15.88%	↓ 1.75%

	FY18	Y/Y Change
Profit	$72.1M	↑ 5.28%

	FY19	Y/Y Change
Profit	$81.5M	↑ 13.09%

	FY20	Y/Y Change
Profit	$84.1M	↑ 3.12%

	FY21	Y/Y Change
Profit	$95.6M	↑ 13.69%

	FY22	Y/Y Change
Profit	$94.5M	↓ 1.13%

	FY23	Y/Y Change
Profit	$92.6M	↓ 2.07%

	Q2 FY23	Q/Q Change
Profit	$22.9M	↑ 2.97%

	Q3 FY23	Q/Q Change
Profit	$23.3M	↑ 2.01%

	Q4 FY23	Q/Q Change
Profit	$22.8M	↓ 2.29%

	Q1 FY24	Q/Q Change
Profit	$20.0M	↓ 12.16%

	Q2 FY24	Q/Q Change
Profit	$20.1M	↑ 0.38%

	Q3 FY24	Q/Q Change
Profit	$20.5M	↑ 2.13%

	FY18	Y/Y Change
Operating Cash Flow	$39.8M	↑ 41.85%
Investing Cash Flow	$-6.0M	↓ 2.4%
Financing Cash Flow	$-54.5M	↑ 158.08%

	FY19	Y/Y Change
Operating Cash Flow	$40.9M	↑ 2.68%
Investing Cash Flow	$-4.7M	↓ 22.02%
Financing Cash Flow	$-36.3M	↓ 33.31%

	FY20	Y/Y Change
Operating Cash Flow	$40.6M	↓ 0.69%
Investing Cash Flow	$-3.7M	↓ 20.02%
Financing Cash Flow	$-15.5M	↓ 57.35%

	FY21	Y/Y Change
Operating Cash Flow	$46.3M	↑ 14.05%
Investing Cash Flow	$-8.5M	↑ 128.63%
Financing Cash Flow	$-18.2M	↑ 17.15%

	FY22	Y/Y Change
Operating Cash Flow	$36.3M	↓ 21.75%
Investing Cash Flow	$-9.8M	↑ 15.52%
Financing Cash Flow	$-55.6M	↑ 206.04%

	Q2 FY23	Q/Q Change
Operating Cash Flow	$8.8M	↑ 13.96%
Investing Cash Flow	$-4.3M	↑ 35.64%
Financing Cash Flow	$-5.7M	↓ 2.25%

National Research Technicals Summary

Sell

Neutral

Buy

National Research is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

National Research (NRC) Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
National Research Corp	-13.81%	-34.87%	-65.04%	-61.19%	-73.14%
Doximity, Inc.	15.46%	90.0%	141.3%	29.72%	27.98%
Solventum Corp	5.87%	20.41%	14.31%	14.31%	14.31%
Ge Healthcare Technologies Inc.	-3.01%	-3.41%	-9.44%	39.38%	39.38%
Veeva Systems Inc.	-6.4%	1.46%	-2.72%	20.36%	57.16%
Healthequity Inc	-6.64%	29.56%	27.86%	101.62%	87.19%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
National Research Corp	13.56	13.56	NA	0.0	0.62	0.17	0.03	1.36
Doximity, Inc.	68.45	68.45	3.81	1.31	0.21	0.13	NA	5.5
Solventum Corp	29.04	29.04	NA	5.52	0.07	0.05	NA	17.13
Ge Healthcare Technologies Inc.	19.92	19.92	2.29	4.68	0.26	0.06	0.0	18.48
Veeva Systems Inc.	53.93	53.93	1.25	6.45	0.13	0.07	NA	33.93
Healthequity Inc	100.79	100.79	1.21	3.15	0.05	0.04	NA	24.47

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
National Research Corp	Sell	$325.5M	-73.14%	13.56	17.32%
Doximity, Inc.	Hold	$12.8B	27.98%	68.45	36.6%
Solventum Corp	Hold	$13.9B	14.31%	29.04	5.8%
Ge Healthcare Technologies Inc.	Buy	$39.5B	39.38%	19.92	10.13%
Veeva Systems Inc.	Buy	$35.5B	57.16%	53.93	25.07%
Healthequity Inc	Buy	$9.5B	87.19%	100.79	8.41%

About National Research

National Research Corporation provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience. Its portfolio of subscription-based solutions provides actionable information and analysis to healthcare organizations across a range of mission-critical, constituent-related elements, including patient experience, service recovery, care transitions, employee engagement, reputation management, and brand loyalty. The company also offers marketing solutions that allow the tracking of awareness, perception, and consistency of healthcare brands; assessment of competitive differentiators; and enhanced segmentation tools to evaluate needs, wants, and behaviors of communities through real-time competitive assessments and enhanced segmentation tools. In addition, it provides experience solutions, such as patient experience, employee engagement, health risk assessments, care transition, and improvement tools. Further, the company provides reputation solutions that allow healthcare organizations to share a picture of their organization and ensure that timely and relevant content informs consumer decision-making; and governance solutions for not-for-profit hospital and health system boards of directors, executives, and physician leadership. National Research Corporation was founded in 1981 and is headquartered in Lincoln, Nebraska.

Organization	National Research
Employees	0
CEO	Mr. Michael D. Hays
Industry	Health Services

Management People of National Research

Name	Title
Mr. Michael D. Hays	Founder, CEO, President & Director
Ms. Helen L. Hrdy	Chief Operating Officer
Mr. Andy Monnich	Chief Corporate Development Officer
Mr. Jon Boumstein	Chief Delivery Officer
Mr. Jason Hahn	Chief Revenue Officer
Ms. Vinitha Ramnathan	Chief Product Officer
Ms. Jennifer Baron	Chief Experience Officer
Ms. Linda Stacy	Secretary
Megan Charko	Senior Manager of Content Marketing

Important FAQs about investing in NRC Stock from India :

What is National Research share price today?

National Research share price today stands at $14.26, Open: $14.20 ; Previous Close: $14.10 ; High: $14.45 ; Low: $13.99 ; 52 Week High: $40.77 ; 52 Week Low: $13.92.

The stock opens at $14.20, after a previous close of $14.10. The stock reached a daily high of $14.45 and a low of $13.99, with a 52-week high of $40.77 and a 52-week low of $13.92.

Can Indians buy National Research shares?

Yes, Indians can invest in the National Research (NRC) from India.

With INDmoney, you can buy National Research at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy National Research at zero transaction cost.

How can I buy National Research shares from India?

It is very easy to buy National Research from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of National Research (NRC) be purchased?

Yes, you can buy fractional shares of National Research with INDmoney app.

What are the documents required to start investing in National Research stocks?

To start investing in National Research, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.